These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20596633)

  • 1. Monoclonal antibodies targeting basic fibroblast growth factor inhibit the growth of B16 melanoma in vivo and in vitro.
    Li D; Wang H; Xiang JJ; Deng N; Wang PP; Kang YL; Tao J; Xu M
    Oncol Rep; 2010 Aug; 24(2):457-63. PubMed ID: 20596633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
    de Aguiar RB; Parise CB; Souza CR; Braggion C; Quintilio W; Moro AM; Navarro Marques FL; Buchpiguel CA; Chammas R; de Moraes JZ
    Cancer Lett; 2016 Feb; 371(2):151-60. PubMed ID: 26655277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer.
    Cai Y; Yao S; Zhong J; Zhang J; Jiang H; Deng Y; Deng N
    Oncotarget; 2017 Mar; 8(12):20187-20197. PubMed ID: 28423625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
    Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
    Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant snake venom cystatin inhibits tumor angiogenesis in vitro and in vivo associated with downregulation of VEGF-A165, Flt-1 and bFGF.
    Xie Q; Tang N; Wan R; Qi Y; Lin X; Lin J
    Anticancer Agents Med Chem; 2013 May; 13(4):663-71. PubMed ID: 23094915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide.
    Zhang Q; Lao X; Huang J; Zhu Z; Pang L; Tang Y; Song Q; Huang J; Deng J; Deng N; Yang Q; Sengupta AM; Xiong L
    Biotechnol Prog; 2015; 31(1):194-203. PubMed ID: 25271020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
    Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
    Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.
    Yu Y; Gao S; Li Q; Wang C; Lai X; Chen X; Wang R; Di J; Li T; Wang W; Wu X
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1321-8. PubMed ID: 22481251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
    Banciu M; Schiffelers RM; Fens MH; Metselaar JM; Storm G
    J Control Release; 2006 Jun; 113(1):1-8. PubMed ID: 16707187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
    Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
    Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
    Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different antitumor activities of anti-bFGF neutralizing antibodies: heparin-binding domain provides an inefficient epitope for neutralization in vivo.
    Aonuma M; Yoshitake Y; Nishikawa K; Tanaka NG
    Anticancer Res; 1999; 19(5B):4039-44. PubMed ID: 10628351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis.
    Valesky M; Spang AJ; Fisher GW; Farkas DL; Becker D
    Mol Med; 2002 Feb; 8(2):103-12. PubMed ID: 12080186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
    Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
    Banciu M; Metselaar JM; Schiffelers RM; Storm G
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):101-10. PubMed ID: 18602825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
    Zhang H; Issekutz AC
    Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
    Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
    FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.